Stocks and Investing Stocks and Investing
Tue, May 2, 2023
Mon, May 1, 2023

Greg Harrison Upgraded (STOK) to Hold and Increased Target to $12 on, May 1st, 2023


Published on 2024-10-28 03:14:08 - WOPRAI, Greg Harrison
  Print publication without navigation


Greg Harrison of B of A Securities, Upgraded "Stoke Therapeutics, Inc." (STOK) to Hold and Increased Target from $9 to $12 on, May 1st, 2023.

Greg has made no other calls on STOK in the last 4 months.



There are 6 other peers that have a rating on STOK. Out of the 6 peers that are also analyzing STOK, 0 agree with Greg's Rating of Hold.



These are the ratings of the 6 analyists that currently disagree with Greg


  • Sumant Kulkarni of "Canaccord Genuity" Initiated at Strong Buy and Held Target at $24 on, Wednesday, April 26th, 2023
  • Joseph Stringer of "Needham" Reiterated at Strong Buy and Held Target at $25 on, Thursday, March 16th, 2023
  • Judah Frommer of "Credit Suisse" Maintained at Buy with Decreased Target to $28 on, Tuesday, March 7th, 2023
  • Laura Chico of "Wedbush" Maintained at Buy with Decreased Target to $25 on, Tuesday, March 7th, 2023
  • Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $35 on, Tuesday, March 7th, 2023
  • Charles Duncan of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $20 on, Tuesday, March 7th, 2023
Contributing Sources